According to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute, sexual impairment is common among men with chronic hepatitis C undergoing antiviral therapy.
This is the first time a study evaluating the combination therapy, peginterferon and ribavirin, has identified sexual dysfunction as a side effect. Sexual dysfunction and impairment […]
continue reading from " Men undergoing chronic hepatitis C treatment experience sexual impairment "
